Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Evelo Biosciences, Inc. EVLO OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
30/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Evelo Biosciences, Inc. (EVLO) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 5 Buy, 3 Hold.

EVLO Analyst Ratings

Buy
8
Ratings
5 Buy
3 Hold
Based on 8 analysts giving stock ratings to Evelo Biosciences, Inc. in the past 3 months
Rating breakdown
Buy
5 63%
Hold
3 38%
63%
Buy
5 analysts
38%
Hold
3 analysts
0%
Sell
0 analysts

People Also View

ERAS
ERAS
Erasca, Inc.
$17.85
+9.44%
 EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
 NUVB
NUVB
Nuvation Bio Inc.
$4.85
+3.19%
 CTMX
CTMX
CytomX Therapeutics, Inc.
$4.54
+3.42%
 ASMB
ASMB
Assembly Biosciences, Inc.
$29.44
+0.68%
 SRZN
SRZN
Surrozen, Inc.
$31.07
+4.05%
 CCCC
CCCC
C4 Therapeutics, Inc.
$2.76
+0.91%
 TIL
TIL
Instil Bio, Inc.
$8.44
+1.02%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message